SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients
Academic Article
Publication Date:
2019
Short description:
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients / Serafin, V.; Porcu, E.; Cortese, G.; Mariotto, E.; Veltri, G.; Bresolin, S.; Basso, G.; Accordi, B.. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 20:24(2019), pp. 6175-N/A. [10.3390/ijms20246175]
Iris type:
Articolo su rivista
Keywords:
Entospletinib; Leukemia; Relapse; SYK
List of contributors:
Serafin, V.; Porcu, E.; Cortese, G.; Mariotto, E.; Veltri, G.; Bresolin, S.; Basso, G.; Accordi, B.
Published in: